1. Academic Validation
  2. Yang-Gan-Jiang-Mei formula alleviates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome through mitophagy

Yang-Gan-Jiang-Mei formula alleviates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome through mitophagy

  • Biotechnol Genet Eng Rev. 2023 Mar 24;1-20. doi: 10.1080/02648725.2023.2193482.
Yuanyuan Wu 1 2 Yufeng Kuang 1 2 Yunbang Wu 1 2 Heng Dai 1 2 Ruiqi Bi 1 2 Jiaming Hu 1 2 Lixia Sun 1 2
Affiliations

Affiliations

  • 1 The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, China.
  • 2 Jiangsu Province Hospital of Chinese Medicine, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Abstract

As an effective formula of traditional Chinese medicine, Yang-Gan-Jiang-Mei (YGJM) formula exhibited a unique advantage in ameliorating liver injury and hepatic steatosis of non-alcoholic steatohepatitis (NASH). Nevertheless, the related pharmacological mechanism needs to be elucidated. This study aimed to explore the molecular mechanism of YGJM formula on Mitophagy mediated by PINK1/parkin signaling pathway and NOD-like Receptor protein 3 (NLRP3) inflammasome in NASH. High-fat-diet rats and HepG2 cells induced by free fatty acid were used as NASH models in vivo and in vitro. Liver pathology and serum indicator embodying liver function (aspartate transferase, alanine transferase, triglyceride, and total Cholesterol) were applied to evaluate the extent of hepatic damage and lipid accumulation. Besides, transmission electron microscopy, JC-1 and 2',7'-dichlorofluorescein diacetate were utilized to observe hepatic mitochondrial morphology, as well as cellular mitochondrial membrane potential and Reactive Oxygen Species level. Additionally, expression of PINK1/parkin-mediated Mitophagy and NLRP3 inflammasome was detected to elucidate the underlying mechanism of YGJM formula by immunohistochemistry, immunofluorescence, RT-PCR (reverse transcription-polymerase chain reaction) and Western blot. The manifestations of pathology and biochemical detection confirmed the efficacy of YGJM formula in relieving hepatic damage and lipid deposition. Simultaneously, YGJM formula could obviously improve mitochondrial function. In addition, YGJM formula exhibited the promotion of PINK1/parkin-mediated Mitophagy, which could perturb NLRP3 inflammasome activation, and as a result, the hepatocyte inflammation was also suppressed both in vitro and in vivo. Our preliminary results indicate that YGJM formula can ameliorate NASH mechanistically by interfering with PINK1/parkin-mediated Mitophagy and NLRP3 inflammasome to exert anti-inflammation ability and promote mitochondrial function restoration.

Keywords

NOD-like receptor protein 3 (NLRP3) inflammasome; Non-alcoholic steatohepatitis (NASH); Yang-Gan-Jiang-Mei (YGJM) formula; mitophagy; traditional Chinese medicine (TCM).

Figures
Products